Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies
ConditionMyopia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorRuihua Wei
About this trial
To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-35 years old, gender not limited; Obtained informed consent.
Disqualifiers
Obvious strabismus and amblyopia
With congenital eye disease, such as congenital cataract, congenital retinal disease
Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
Trial design
Design model
Parallel
Treatments tested in this trial
Eyerising RS-200-2A
DeviceEyerising RS-200-2A,1 time,2 times, 3 times a day
Airdoc Sky-n1201
DeviceEyerising RS-200-2A,2 times a day
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: The Laser GroupExperimental treatment 1 intervention
Group B: The LED GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Axial length
Time frame
From enrollment to the end of treatment up to 7 monthsSecondary outcomes
1
Spherical equivalent
Time frame
From enrollment to the end of treatment up to 7 months2
Choroidal thickness
Time frame
From enrollment to the end of treatment up to 7 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Ruihua Wei
Lead sponsor
Tianjin Medical University Eye Hospital
Sponsor institution
Tianjin Medical University Eye Hospital
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: